↓
 

Tag Archives: genitourinary oncology

Dr. Petros Grivas: The Journey from Greece to the US, and the Difficult Question of When to Move

Dr. Petros Grivas, genitourinary (GU) cancer expert at the Univ of Washington/Seattle Cancer Care Alliance, describes his path from Greece to the US, his compulsion to deliver, & the challenge of deciding when to stay vs. move on for new opportunities. (55:24)

Dr. Tim Gilligan (Pt. 1): Developing a Focus on Genitourinary Oncology

Host Jack West, MD speaks with Timothy Gilligan, MD, FASCO from Cleveland Clinic, reviewing his path into medicine & genitourinary oncology, then discussing new challenges in testicular, bladder, and prostate cancer management. (30:56)

Dr. Monty Pal: From an Early Commitment to Medicine Down the Path to ASCO & GU Oncology Leadership

Dr. Sumanta (Monty) Pal of City of Hope Comprehensive Cancer Center describes his precocious entry into medicine, the tremendous opportunities it has afforded him in ASCO leadership and GU oncology, his commitment to mentorship, & his work/life balance. (32:11)

TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: Highlights in GU Oncology from ASCO 2018 (BMIC-061)

Dr. Dan Goldstein reviews results of a trial of chemo regimen TIP (paclitaxel, ifosfamide, cisplatin) vs BEP (bleomycin, etoposide, cisplatin) for intermediate/poor risk germ cell tumors, with discussion of outcomes in patients with a p53 mutation. (3:39)

Download MP3 Audio Version

↑